Literature DB >> 16647613

Are blood pressure predictors of cardiovascular disease mortality different for prehypertensives than for hypertensives?

James Greenberg1.   

Abstract

BACKGROUND: The ability of diastolic, systolic, mean arterial, and pulse pressures to predict cardiovascular disease (CVD) morality has not been assessed for persons with prehypertension (diastolic pressure 80 to 89 mm Hg or systolic pressure 120 to 139 mm Hg).
METHODS: Cox's regression analyses were conducted using 4849 subjects aged 33 to 87 years from the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. A correction was made for the regression-dilution bias.
RESULTS: There were 327 cardiovascular disease and 258 coronary heart-disease deaths during an average follow-up of 8.6 years. For nonelderly prehypertensives, systolic blood pressure (BP) was a stronger predictor than diastolic BP. The multivariate single predictor hazard ratios (95% confidence interval) for CVD mortality were 1.43 (0.65-3.14) and 2.11 (1.28-3.49), for a 10 mm Hg increment diastolic and systolic BP, respectively. For elderly prehypertensives, it was reversed. The equivalent results were 1.53 (1.10-2.13) and 1.25 (0.89-1.60), respectively. For nonelderly hypertensives, diastolic BP was a stronger predictor than systolic BP, and for elderly hypertensives it was reversed. Diastolic and systolic BP provided as much as or more predictive information than pulse and mean arterial pressure in all analyses.
CONCLUSIONS: For nonelderly prehypertensives, systolic BP was the strongest predictor, whereas for hypertensives the strongest predictor was diastolic BP. For elderly subjects this pattern was reversed.

Entities:  

Mesh:

Year:  2006        PMID: 16647613     DOI: 10.1016/j.amjhyper.2005.10.023

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.

Authors:  S Biesinger; H A Michaels; A S Quadros; Y Qian; A B Rabovsky; R S Badger; T Jalili
Journal:  Eur J Clin Nutr       Date:  2015-06-10       Impact factor: 4.016

2.  Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction.

Authors:  Daniel H Katz; Rahul C Deo; Frank G Aguilar; Senthil Selvaraj; Eva E Martinez; Lauren Beussink-Nelson; Kwang-Youn A Kim; Jie Peng; Marguerite R Irvin; Hemant Tiwari; D C Rao; Donna K Arnett; Sanjiv J Shah
Journal:  J Cardiovasc Transl Res       Date:  2017-03-03       Impact factor: 4.132

3.  Utilizing stratified generalized propensity score matching to approximate blocked randomized designs with multiple treatment levels.

Authors:  Nathan Corder; Shu Yang
Journal:  J Biopharm Stat       Date:  2022-06-19       Impact factor: 1.503

4.  Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study.

Authors:  Tsogzolmaa Dorjgochoo; Xiao Ou Shu; Xianglan Zhang; Honglan Li; Gong Yang; Lifeng Gao; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.